Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Lipocine Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +2 vs. Q1 2022
- Shares held
- 11.9M
- −9.44K (−0.1%) vs. Q1 2022
- Total value
- $9.54M
- −$92.4M (−90.6%) vs. Q1 2022
- New holders
- 9
- 10 more added
- Sold out
- 7
- 13 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $26.2M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.45M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.47M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $16.6M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $102.0M |
| Q4 2021 | 39 | $10.7M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,797,282 | $3.04M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,612,994 | $1.29M | 0.00% | +48,302+3.1% | Added |
| Wealth Effects LLC | 1,480,334 | $1.19M | 0.71% | −10,500−0.7% | Reduced |
| Geode Capital Management, LLC | 832,079 | $666.0K | 0.00% | +9,024+1.1% | Added |
| Two Sigma Investments, LP | 458,678 | $367.0K | 0.00% | +98,608+27.4% | Added |
| Marshall Wace, LLP | 440,658 | $353.0K | 0.00% | −122,012−21.7% | Reduced |
| Bridgeway Capital Management, LLC | 425,664 | $341.0K | 0.01% | +248,800+140.7% | Added |
| State Street Corp | 316,633 | $254.0K | 0.00% | −10,772−3.3% | Reduced |
| Mercer Global Advisors Inc | 309,111 | $248.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 309,600 | $248.0K | 0.00% | +167,200+117.4% | Added |
| Kestra Advisory Services, LLC | 274,800 | $220.0K | 0.00% | −32,500−10.6% | Reduced |
| Millennium Management LLC | 200,066 | $160.0K | 0.00% | +200,066 | New |
| Price T Rowe Associates Inc | 184,662 | $148.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 160,603 | $129.0K | 0.00% | −7,622−4.5% | Reduced |
| Aaron Wealth Advisors | 145,045 | $116.0K | 0.03% | +27,493+23.4% | Added |
| Acadian Asset Management LLC | 85,070 | $68.0K | 0.00% | +85,070 | New |
| Renaissance Technologies LLC | 81,006 | $65.0K | 0.00% | +66,906+474.5% | Added |
| MML Investors Services, LLC | 77,000 | $62.0K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 74,400 | $60.0K | 0.00% | +74,400 | New |
| Ameriprise Financial Inc | 66,500 | $53.0K | 0.00% | 00.0% | Unchanged |
| RSM US Wealth Management LLC | 65,212 | $52.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 62,750 | $50.0K | 0.00% | −7,500−10.7% | Reduced |
| Morgan Stanley | 56,987 | $45.0K | 0.00% | +16,164+39.6% | Added |
| Bank of New York Mellon Corp | 52,960 | $42.0K | 0.00% | −2,244−4.1% | Reduced |
| Carson Advisory Inc. | 52,000 | $42.0K | 0.05% | +52,000 | New |
| Charles Schwab Investment Management Inc | 50,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 32,085 | $26.0K | 0.00% | +2,186+7.3% | Added |
| Merit Financial Group, LLC | 29,900 | $24.0K | 0.00% | +29,900 | New |
| Jane Street Group, LLC | 26,876 | $22.0K | 0.00% | −3,883−12.6% | Reduced |
| Goldman Sachs Group Inc | 25,952 | $21.0K | 0.00% | −62,663−70.7% | Reduced |
| Moloney Securities Asset Management, LLC | 22,500 | $18.0K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 20,152 | $16.0K | 0.03% | +20,152 | New |
| Plante Moran Financial Advisors, LLC | 17,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 13,000 | $10.0K | 0.00% | −900−6.5% | Reduced |
| Snowden Capital Advisors LLC | 12,578 | $10.0K | 0.00% | +12,578 | New |
| Raymond James & Associates | 10,902 | $9.00K | 0.00% | +10,902 | New |
| Creative Planning | 10,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,592 | $2.00K | 0.00% | +49+1.4% | Added |
| JPMorgan Chase & Co | 3,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,150 | $1.00K | 0.00% | −350−23.3% | Reduced |
| Bank of America Corp | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 1,407 | $1.00K | 0.00% | +1,407 | New |
| UBS Group AG | 500 | $0 | 0.00% | −6,862−93.2% | Reduced |
| FMR LLC | 108 | $0 | 0.00% | −32−22.9% | Reduced |
| Walleye Trading LLC | 101 | $0 | 0.00% | 00.0% | Unchanged |
| EAM Investors, LLC | 0 | $0 | 0.00% | −657,804−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −124,550−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −63,135−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −39,357−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −18,905−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,554−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |